IACIX | VMVAX | IACIX / VMVAX | |
Total Expense Ratio | 0.85 | 0.07 | 1,214% |
Annual Report Gross Expense Ratio | 1.13 | 0.07 | 1,614% |
Fund Existence | 23 years | 14 years | - |
Gain YTD | -3.907 | 6.339 | -62% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 273M | 32.5B | 1% |
Annual Yield % from dividends | 2.00 | 2.17 | 92% |
Returns for 1 year | -6.50 | 1.20 | -540% |
Returns for 3 years | 3.34 | 36.10 | 9% |
Returns for 5 years | 11.87 | 63.10 | 19% |
Returns for 10 years | 10.05 | 99.51 | 10% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PSIFX | 50.27 | 0.27 | +0.54% |
PGIM Quant Solutions Large-Cap Index Z | |||
LCFLX | 14.80 | 0.08 | +0.54% |
Lord Abbett Focused Large Cap Value C | |||
QCACX | 45.21 | 0.19 | +0.42% |
Federated Hermes MDT All Cap Core C | |||
RGLJX | 27.93 | 0.01 | +0.04% |
American Funds Global Insight R-5E | |||
LGCOX | 19.74 | -0.02 | -0.10% |
Lord Abbett Global Equity F3 |